As a novel drug-drug cocrystal, sacubitril allisartan calcium (S086) has demonstrated significant efficacy in the treatment of hypertension and heart failure. S086 has two crystalline forms (α and ξ) with the same molecular composition, but only the crystal structure of the latter has been disclosed. Using the carboxylic group (COO−) and the amide group (CONH) as structural probes, the core structures and local dynamics of the Ca2+ coordination complex in the unit cell of the two cocrystals were examined by ultrafast two-dimensional infrared (2D IR) spectroscopy. A notable variation in the molar ratio of bidentate to bridging binding types of COO− groups that bind to Ca2+ was first identified between the two crystal forms by linear IR spectroscopy. This variation is accompanied by greater local structural rigidity of the α-crystal compared to that of the ξ-crystal, as evidenced by a greater residual amplitude in the spectral diffusion dynamics extracted from the time-dependent 2D IR spectroscopy. Vibrational energy transfer between the bidentate and tridentate COO− groups in the α-crystal was found to be faster than that in the ξ-crystal, suggesting shorter intermolecular distances between EXP3174 and sacubitril in the former. These findings provide dynamical structural parameters that help to understand the stability and releasing mechanisms of the drug molecules.
Skip Nav Destination
,
,
,
,
,
,
,
,
,
Article navigation
14 March 2025
Research Article|
March 17 2025
Local structural dynamics and vibrational energy transfer in an angiotensin receptor-neprilysin inhibitor by ultrafast 2D IR spectroscopy Available to Purchase
Special Collection:
David Jonas Festschrift
Haiyan Xu
;
Haiyan Xu
(Data curation, Formal analysis, Investigation, Writing – original draft)
1
Beijing National Laboratory for Molecular Sciences, Molecular Reaction Dynamics Laboratory, CAS Research/Education Center for Excellence in Molecular Sciences, Institute of Chemistry, Chinese Academy of Sciences
, Beijing 100190, People’s Republic of China
2
University of Chinese Academy of Sciences
, Beijing 100049, People’s Republic of China
Search for other works by this author on:
Wenjie Xu
;
Wenjie Xu
(Funding acquisition, Investigation)
3
Shenzhen Salubris Pharmaceutical Co., Ltd.
, Shenzhen, Guangdong 518118, People’s Republic of China
Search for other works by this author on:
Yueting Zhao
;
Yueting Zhao
(Data curation, Investigation)
1
Beijing National Laboratory for Molecular Sciences, Molecular Reaction Dynamics Laboratory, CAS Research/Education Center for Excellence in Molecular Sciences, Institute of Chemistry, Chinese Academy of Sciences
, Beijing 100190, People’s Republic of China
2
University of Chinese Academy of Sciences
, Beijing 100049, People’s Republic of China
Search for other works by this author on:
Pengyun Yu
;
Pengyun Yu
a)
(Formal analysis, Investigation)
1
Beijing National Laboratory for Molecular Sciences, Molecular Reaction Dynamics Laboratory, CAS Research/Education Center for Excellence in Molecular Sciences, Institute of Chemistry, Chinese Academy of Sciences
, Beijing 100190, People’s Republic of China
2
University of Chinese Academy of Sciences
, Beijing 100049, People’s Republic of China
Search for other works by this author on:
Yiran Miao
;
Yiran Miao
(Investigation)
1
Beijing National Laboratory for Molecular Sciences, Molecular Reaction Dynamics Laboratory, CAS Research/Education Center for Excellence in Molecular Sciences, Institute of Chemistry, Chinese Academy of Sciences
, Beijing 100190, People’s Republic of China
2
University of Chinese Academy of Sciences
, Beijing 100049, People’s Republic of China
Search for other works by this author on:
Lin Tong
;
Lin Tong
(Investigation)
1
Beijing National Laboratory for Molecular Sciences, Molecular Reaction Dynamics Laboratory, CAS Research/Education Center for Excellence in Molecular Sciences, Institute of Chemistry, Chinese Academy of Sciences
, Beijing 100190, People’s Republic of China
2
University of Chinese Academy of Sciences
, Beijing 100049, People’s Republic of China
Search for other works by this author on:
Jie Yan
;
Jie Yan
(Funding acquisition, Investigation, Resources)
3
Shenzhen Salubris Pharmaceutical Co., Ltd.
, Shenzhen, Guangdong 518118, People’s Republic of China
Search for other works by this author on:
Song Li
;
Song Li
(Funding acquisition, Resources)
3
Shenzhen Salubris Pharmaceutical Co., Ltd.
, Shenzhen, Guangdong 518118, People’s Republic of China
Search for other works by this author on:
Fan Yang
;
Fan Yang
(Investigation, Resources)
1
Beijing National Laboratory for Molecular Sciences, Molecular Reaction Dynamics Laboratory, CAS Research/Education Center for Excellence in Molecular Sciences, Institute of Chemistry, Chinese Academy of Sciences
, Beijing 100190, People’s Republic of China
2
University of Chinese Academy of Sciences
, Beijing 100049, People’s Republic of China
Search for other works by this author on:
Jianping Wang
Jianping Wang
b)
(Funding acquisition, Resources, Writing – original draft, Writing – review & editing)
1
Beijing National Laboratory for Molecular Sciences, Molecular Reaction Dynamics Laboratory, CAS Research/Education Center for Excellence in Molecular Sciences, Institute of Chemistry, Chinese Academy of Sciences
, Beijing 100190, People’s Republic of China
2
University of Chinese Academy of Sciences
, Beijing 100049, People’s Republic of China
b)Author to whom correspondence should be addressed: [email protected]. Tel.: (+86)-010-62656806. Fax: (+86)-010-62563167
Search for other works by this author on:
Haiyan Xu
1,2
Wenjie Xu
3
Yueting Zhao
1,2
Pengyun Yu
1,2,a)
Yiran Miao
1,2
Lin Tong
1,2
Jie Yan
3
Song Li
3
Fan Yang
1,2
Jianping Wang
1,2,b)
1
Beijing National Laboratory for Molecular Sciences, Molecular Reaction Dynamics Laboratory, CAS Research/Education Center for Excellence in Molecular Sciences, Institute of Chemistry, Chinese Academy of Sciences
, Beijing 100190, People’s Republic of China
2
University of Chinese Academy of Sciences
, Beijing 100049, People’s Republic of China
3
Shenzhen Salubris Pharmaceutical Co., Ltd.
, Shenzhen, Guangdong 518118, People’s Republic of China
b)Author to whom correspondence should be addressed: [email protected]. Tel.: (+86)-010-62656806. Fax: (+86)-010-62563167
a)
Present address: Hefei National Laboratory for Physical Sciences at the Microscale, University of Science and Technology of China, Hefei 230026, China.
J. Chem. Phys. 162, 114903 (2025)
Article history
Received:
December 28 2024
Accepted:
February 20 2025
Citation
Haiyan Xu, Wenjie Xu, Yueting Zhao, Pengyun Yu, Yiran Miao, Lin Tong, Jie Yan, Song Li, Fan Yang, Jianping Wang; Local structural dynamics and vibrational energy transfer in an angiotensin receptor-neprilysin inhibitor by ultrafast 2D IR spectroscopy. J. Chem. Phys. 14 March 2025; 162 (11): 114903. https://doi.org/10.1063/5.0255358
Download citation file:
Pay-Per-View Access
$40.00
Sign In
You could not be signed in. Please check your credentials and make sure you have an active account and try again.
146
Views
Citing articles via
The Amsterdam Modeling Suite
Evert Jan Baerends, Nestor F. Aguirre, et al.
DeePMD-kit v2: A software package for deep potential models
Jinzhe Zeng, Duo Zhang, et al.
CREST—A program for the exploration of low-energy molecular chemical space
Philipp Pracht, Stefan Grimme, et al.
Related Content
Antioxidant potential of ethanolic extract of Sargassum polycystum C.A. Agardh. naturally growing in Lange seashore
AIP Conf. Proc. (December 2022)
Molecular docking analysis of tetradodecanoic from Coix essential oil as potential ACE2 inhibitors for SARS-CoV-2 anti-viral
AIP Conf. Proc. (November 2022)